Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
BCLI
BrainStorm Cell Therapeutics Inc.
126
Follow
126
BCLI
BrainStorm Cell Therapeutics Inc.
126
Follow
126
Likes Subject
Older
Our valuation remains at $20 per share. midastouch017 04/06/23 1:24 AM
From Zacks: Fmello 04/04/23 4:46 PM
https://www.neurologylive.com/view/critical-importance-fda-adcomm-meeting-als-th Fmello 04/03/23 4:50 PM
BCLI stock rose 80.33% in five days! Fmello 04/01/23 11:46 AM
https://seekingalpha.com/article/4591218-brainstorm-upcoming-adcom-meeting-for-n Fmello 03/30/23 9:40 AM
https://www.cgtlive.com/view/stacy-lindborg-phd-upcoming-fda-advisory-committee- Fmello 03/28/23 10:46 PM
From Michelle Lorenz post on No More Excuses: Fmello 02/24/23 3:34 PM
I just read this post on the No Fmello 02/15/23 2:21 PM
No clue. Hope it turns around by the Fmello 02/06/23 11:40 AM
Started the day up... whats going on Robinsold 02/06/23 10:59 AM
Ouch...down -18.89% do far today. Fmello 02/06/23 10:57 AM
Nice movement this week, hope it's due to leakage... bubbarayjr 02/04/23 6:07 AM
We're up +$1.18 (77.63%) in the past 5 Fmello 02/03/23 4:40 PM
Stock manipulation. midastouch017 02/03/23 12:24 AM
Up 46.58% over the past 5 days. Fmello 02/02/23 7:18 PM
Biotech Showcase Fmello 01/30/23 11:13 AM
Brainstorm Cell Therapeutics (BCLI) Receives a Buy from Fmello 01/11/23 5:13 PM
BrainStorm Preps for Type A NurOwn Meeting, Shakes Fmello 01/07/23 11:07 AM
https://www.pbs.org/newshour/show/former-obama-staffer-fights-to-raise-als-aware Fmello 01/01/23 10:55 PM
That's definitely good news. Hopefully they can set Fmello 12/27/22 9:16 AM
BrainStorm Cell Therapeutics Announces Type A Meeting with midastouch017 12/27/22 8:27 AM
BrainStorm Cell Therapeutics Submits Type A Meeting Request Fmello 12/12/22 10:32 AM
West Virginia man battling ALS hoping FDA reverses Fmello 12/07/22 11:15 AM
https://twitter.com/aVoice4ALS/status/1600145112478060545?s=20&t=EE0XtBdI5ak5Xhd Fmello 12/06/22 12:33 PM
No annual shareholder meeting date has been released condoe3 12/05/22 5:35 PM
https://www.facebook.com/michelle.lorenz.395/videos/826580615242103?idorvanity=1
Bullish
Bullish
 Fmello 12/03/22 1:55 AM
Dramatic letter from Esteban Bulrich to Joe Biden Fmello 11/30/22 2:26 PM
https://twitter.com/Smithstrongmom1/status/1265993948918579206?s=20&t=8wNn29KSZv Fmello 11/29/22 1:34 PM
Fort Smith man losing hope after FDA denies Fmello 11/25/22 1:37 PM
I Am ALS and Veterans with ALS send Fmello 11/23/22 3:53 PM
Stevens Nation Responds to FDA's Refusal to File
Bullish
Bullish
 Fmello 11/22/22 8:41 PM
Any idea what caused this huge spike to
Bullish
Bullish
 Fmello 11/22/22 1:38 PM
BrainStorm Vows to Push for Adcomm Meeting on Fmello 11/14/22 1:20 PM
Mike Hensen & Michelle Lorenz going LIVE @ Fmello 11/10/22 5:51 PM
https://i.imgur.com/iqYg4wp.png Fmello 11/10/22 12:43 PM
BCLI - The End Of Story! midastouch017 11/10/22 8:37 AM
BrainStorm Cell Therapeutics Receives Refusal to File Letter Fmello 11/10/22 8:34 AM
NurOwn Continues to Show Benefit in Rapidly Advancing ALS Fmello 11/09/22 7:23 PM
NurOwn Stromal Cell Therapy Continues to Show Positive Fmello 11/09/22 7:19 PM
BrainStorm Cell Therapeutics to Announce Third Quarter Results midastouch017 11/08/22 12:35 AM
https://imgur.com/GdhT6aX.jpg Fmello 11/07/22 7:42 AM
BrainStorm Cell Therapeutics Presents New Analyses from NurOwn's midastouch017 11/07/22 7:33 AM
BrainStorm Cell Therapeutics Presents New Analyses from NurOwn's Fmello 11/07/22 7:27 AM
“Every day thousands of patients die from aging-associated sokol 10/29/22 9:46 AM
BrainStorm Cell Therapeutics Presents NurOwn® Phase 2 Progressive midastouch017 10/20/22 6:09 AM
https://alsnewstoday.com/news/als-biomarkers-boosted-nurown-regardless-disease-s Fmello 10/13/22 3:16 PM
This is from a post on the No Fmello 10/12/22 7:25 PM
Hopefully the latter, but my guess is the murocman 10/12/22 6:22 PM
At 26:07, Lindborg mentions, Fmello 10/12/22 2:43 PM
https://www.youtube.com/watch?v=qwttt4VZbe8 Fmello 10/12/22 2:04 PM
Likes Subject
Older

Older
midastouch017
04/06/23 1:24 AM
Fmello
04/04/23 4:46 PM
Fmello
04/03/23 4:50 PM
Fmello
04/01/23 11:46 AM
Fmello
03/30/23 9:40 AM
Fmello
03/28/23 10:46 PM
Fmello
02/24/23 3:34 PM
Fmello
02/15/23 2:21 PM
Fmello
02/06/23 11:40 AM
Robinsold
02/06/23 10:59 AM
Fmello
02/06/23 10:57 AM
bubbarayjr
02/04/23 6:07 AM
Fmello
02/03/23 4:40 PM
midastouch017
02/03/23 12:24 AM
Fmello
02/02/23 7:18 PM
Fmello
01/30/23 11:13 AM
Fmello
01/11/23 5:13 PM
Fmello
01/07/23 11:07 AM
Fmello
01/01/23 10:55 PM
Fmello
12/27/22 9:16 AM
midastouch017
12/27/22 8:27 AM
Fmello
12/12/22 10:32 AM
Fmello
12/07/22 11:15 AM
Fmello
12/06/22 12:33 PM
condoe3
12/05/22 5:35 PM
Fmello
12/03/22 1:55 AM
Bullish
Fmello
11/30/22 2:26 PM
Fmello
11/29/22 1:34 PM
Fmello
11/25/22 1:37 PM
Fmello
11/23/22 3:53 PM
Fmello
11/22/22 8:41 PM
Bullish
Fmello
11/22/22 1:38 PM
Bullish
Fmello
11/14/22 1:20 PM
Fmello
11/10/22 5:51 PM
Fmello
11/10/22 12:43 PM
midastouch017
11/10/22 8:37 AM
Fmello
11/10/22 8:34 AM
Fmello
11/09/22 7:23 PM
Fmello
11/09/22 7:19 PM
midastouch017
11/08/22 12:35 AM
Fmello
11/07/22 7:42 AM
midastouch017
11/07/22 7:33 AM
Fmello
11/07/22 7:27 AM
sokol
10/29/22 9:46 AM
midastouch017
10/20/22 6:09 AM
Fmello
10/13/22 3:16 PM
Fmello
10/12/22 7:25 PM
murocman
10/12/22 6:22 PM
Fmello
10/12/22 2:43 PM
Fmello
10/12/22 2:04 PM

BrainStorm Cell Therapeutics Inc. (BCLI)

Followers
126
Posters
318
Posts (Today)
0
Posts (Total)
3287
Created
11/30/05
Type
Free
Moderators








BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The Company holds the rights to clinical development and commercialization of the NurOwn technology platform used to produce autologous MSC-NTF cells through an exclusive, worldwide licensing agreement. Autologous MSC-NTF cells have received Orphan Drug status designation from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm has fully enrolled a Phase 3 pivotal trial in ALS (NCT03280056), investigating repeat-administration of autologous MSC-NTF cells at six U.S. sites supported by a grant from the California Institute for Regenerative Medicine (CIRM CLIN2-0989). The pivotal study is intended to support a filing for U.S. FDA approval of autologous MSC-NTF cells in ALS. BrainStorm also recently received U.S. FDA clearance to initiate a Phase 2 open-label multicenter trial in progressive multiple sclerosis (MS). The Phase 2 study of autologous MSC-NTF cells in patients with progressive MS (NCT03799718) started enrollment in March 2019. 

Brainstorm Cell Therapeutics Inc.

1325 Avenue of Americas
28th Floor
New York, NY 10019
United States
201-488-0460
http://www.brainstorm-cell.com



 

Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
Upgrade to Real-Time
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
BCLI Latest News
More BCLI News
Most Liked Posts
(Last 30 Days)
New Post